Abstract
We report a case of a 17-year-old girl with a history of congenital human immunodeficiency virus (HIV) infection and lipodystrophy secondary to highly active antiretroviral therapy (HAART). She developed severe worsening of preexisting hypertriglyceridemia after treatment with oral contraceptive pills (OCP) for polycystic ovary syndrome. Her hypertriglyceridemia improved upon OCP discontinuation. Although it is known that estrogen combined with progestins have a negative effect on triglycerides and high-density lipoprotein (HDL) cholesterol levels, to our knowledge the association of HAART-related lipodystrophy and severe hypertriglyceridemia after OCP use has not been reported in the literature. We recommend avoiding the use of OCPs in patients with lipodystrophy due to the increased risk of worsening hypertriglyceridemia.
References
1. Jain SS, Ramteke KB, Raparti GT, Kalra S. Pathogenesis and treatment of human immunodeficiency virus lipodystrophy. Indian J Endocrinol Metab 2012;16(Suppl 1):S20–6.10.4103/2230-8210.94250Search in Google Scholar
2. Abhimanyu G. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Mebab 2011;96:3313–25.10.1210/jc.2011-1159Search in Google Scholar
3. Carr A, Samaras K, Burton S, Law M, Freund J, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51–8.10.1097/00002030-199807000-00003Search in Google Scholar
4. Vigano A, Manzoni P, Riva S, Brambilla P, Ferrazzi E, et al. Hyperinsulinemia induced by highly active antiretroviral therapy in an adolescent with polycystic ovary syndrome who was infected with human immunodeficiency virus. Fertility Sterility 2003;79:422–3.10.1016/S0015-0282(02)04693-9Search in Google Scholar
5. Sinha U, Sinharay K, Sengupta N, Mukhopadhyay P. Benefits of leptin therapy in HIV patients. Indian J Endocrinol Metab 2012;16:S637–43.10.4103/2230-8210.105583Search in Google Scholar
6. Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antiviral Res 2001;51:151–77.10.1016/S0166-3542(01)00148-6Search in Google Scholar
7. Galli M, Veglia F, Angarano G, Santambrogio S, Meneghini E, et al. Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 2003;34:58–61.10.1097/00126334-200309010-00008Search in Google Scholar
8. Collazos J, Mayo J, Martinez E, Ibarra S. Association between sexual disturbances and sexual hormones with specific antiretroviral drugs. AIDS 2002;16:1294–95.10.1097/00002030-200206140-00016Search in Google Scholar
9. Crook D, Godsland IF, Wynn V. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. Am J Obstet Gynecol 1988;158:1612–20.10.1016/0002-9378(88)90199-8Search in Google Scholar
10. Yauger BJ, Gorden P, Park J, Cochran E, Stratton P. Effect of depot medroxyprogesterone acetate on glucose tolerance in generalized lipodystrophy. Obstet Gynecol 2008;112:445–7.10.1097/AOG.0b013e3181662d17Search in Google Scholar PubMed PubMed Central
11. Womack J, Richman S, Tien P, Grey M, Williams A. Hormonal contraception and HIV-positive women: metabolic concerns and management strategies. J Midwifery Womens Health 2008;53:362–75.10.1016/j.jmwh.2008.01.006Search in Google Scholar
12. Halperin I, Kumar S, Stroup D, Laredo S. The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies. Human Reproduction 2011;26:191–201.10.1093/humrep/deq301Search in Google Scholar
13. Pedersen SB, Bruun JM, Hube F, Kristensen K, Hauner H, et al. Demonstration of estrogen receptor subtypes a and b in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol 2001;182:27–37.10.1016/S0303-7207(01)00557-3Search in Google Scholar
14. Couse JF, Korach KS. Estrogen receptor null mice: what we have learned and where will they lead us? Endocr Rev 1999;20:358–417.10.1210/edrv.20.3.0370Search in Google Scholar
15. Barzon L, Zamboni M, Pacenti M, Milan G, Bosello O, et al. Do oestrogen receptors play a role in the pathogenesis of HIV-associated lipodystrophy? AIDS 2005;19:531–3.10.1097/01.aids.0000162344.73804.a1Search in Google Scholar
16. Andersen O, Pedersen SB, Svenstrup B, Hansen BR, Paulsen SK, et al. Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV lipodystrophy: implications for fat distribution. Clin Endocrinol 2007;67:250–8.10.1111/j.1365-2265.2007.02872.xSearch in Google Scholar
17. Ledergerber B, Furrer H, Rickenbach M, Lehmann R, Elzi L, et al.; Swiss HIV Cohort Study. Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clin Infect Dis 2007;45:111–9.10.1086/518619Search in Google Scholar
18. Baptiste CG, Battista MC, Trottier A, Baillargeon JP. Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 2010;122:42–52.10.1016/j.jsbmb.2009.12.010Search in Google Scholar
19. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrinol Rev 1997;18:774–800.Search in Google Scholar
20. Dejkhamron P, Unachak K, Chhabra M, Oberdorfer P. A HIV-infected adolescent with polycystic ovary syndrome. Pediatr J Infect Dis 2011;6:45–9.10.3233/JPI-2011-0284Search in Google Scholar
21. Bergh C, Carlsson B, Olsson JH, Selleskog U, Hillensjö T. Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin. Fertil Steril 1993;59:323–31.10.1016/S0015-0282(16)55675-1Search in Google Scholar
22. Barbieri RL, Makris A, Ryan KJ. Insulin stimulates androgen accumulation in incubations of human ovarian stroma and theca. Obstet Gynecol 1984;64:73S–80S.10.1097/00006250-198409001-00019Search in Google Scholar PubMed
23. Hadigan C, Corcoran C, Piecuch S, Rodriguez W, Grinspoon S. Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome. Canadian J Emerg Med 2000;85:3544–50.10.1210/jc.85.10.3544Search in Google Scholar
©2014 by De Gruyter
